Colloidal bismuth tartrate capsules

This product is a gastrointestinal mucosal protective drug. After oral administration, it forms a sol with excellent colloidal properties in the gastric juice, which has a strong affinity with the ulcer surface and the inflamed surface, and can form an effective protective film to isolate gastric acid, protect the damaged mucosa, and stimulate the gastrointestinal mucosal epithelial cells to secrete mucus, promoting the self-repair of epithelial cells. This product has excellent adhesion to the damaged mucosa and has a hemostatic effect. This product can also kill gastric Helicobacter pylori. Animal experiments show that this product can reduce the number of ulcers in experimental ulcerative colitis rabbits, reduce the diameter of ulcers, and reduce the number of bowel movements and loose stools in experimental ulcerative colitis rabbits and rats.

Colloidal bismuth tartrate.

This product is suitable for the treatment of peptic ulcers, especially Helicobacter pylori-related ulcers. It can also be used for chronic colitis, diarrhea caused by ulcerative colitis, and chronic superficial and atrophic gastritis.

Oral administration: 165 mg once, 4 times a day, 1 hour before 3 meals and before going to bed.

Occasionally, gastrointestinal symptoms such as nausea and constipation may occur.

It is contraindicated for patients who are allergic to this product or have renal insufficiency.

This product should not be taken at the same time as antacids, milk and H2 receptor blockers, otherwise the efficacy of the product will be reduced.

Keep in a light-proof, airtight and dry place.

165mg (as bismuth)

Foshan Huapu Pharmaceutical Co., Ltd.

• Founded in:

  2009-09-18

• Address:

  North side of National Highway 321, Xianxi First Industrial Zone, Yanfeng Village, Shishan Town, Nanhai District, Foshan City

• Tax NO.:

  91440605694750892B

• Registered Funds:

  3 million yuan

• Email:

  Log in to view